Tag: TRANSFORM-AF
Multicentre study suggests GLP-1 receptor agonists may reduce AF-related events in...
The TRANSFORM-AF study has found that patients with atrial fibrillation (AF) and obesity who were treated with a glucagon-like peptide-1 receptor agonist (GLP-1 RA)...